Hormone therapy use and duration with postoperative radiotherapy for recurrent prostate cancer: an individual patient data meta-analysis

By afschroeder • March 2, 2026

Kishan AU, Sun Y, Parker CC, Sargos P, Sydes MR, Chabaud S, Brihoum M, Kalbasi TR, Steinberg ML, Valle LF, Taparra K, Shoag JE, Garcia JA, Brown JR, Rettig MB, Singer AE, Reiter RE, Eggener S, Brisbane W, Roy S, Zaorsky NG, Jia AY, Ma TM, Nickols NG, Efstathiou JA, Mohamad O, Dignam JJ, Seiferheld WF, Pollack A, Sandler HM, Nguyen PL, Pommier P, Spratt DE. Hormone therapy use and duration with postoperative radiotherapy for recurrent prostate cancer: an individual patient data meta-analysis. Lancet. 2026 Feb 26:S0140-6736(26)00137-6. doi: 10.1016/S0140-6736(26)00137-6. Epub ahead of print. PMID: 41765025.

Tags: DOM STAT, General Internal Medicine, Hematology/Oncology, Publications, Veterans Administration

Changing Clinician Behavior in Geriatrics: Point-of-Care Alerts for Prostate-Specific Antigen Screening

Duong N, Lee JY, Peprah Y, Brown T, Linder JA, Doctor JN, Meeker D, Fox CR, Goldstein NJ, Persell SD, Petito LC. Changing Clinician Behavior[...]

Centralization of Lung Cancer Screening and Adherence to First Follow-up Assessment: The Veterans Health Administration Experience

Benjamin LN, Núñez ER, Chen L, Motwani Y, Yuan A, Vangala S, Slatore CG, Wiener RS, Elashoff DA, Yano EM, Washington DL, Mangione CM. Centralization[...]

Methylation plus alpha-fetoprotein blood test for early detection of HCC in at-risk populations

Parikh ND, Liu CC, DeMaio M, Yeh AH, Stackpole ML, Li S, Agopian VG, Li W, Zhou XJ, Ni X, Lok AS, Han SB. Methylation[...]